| Revenue | NOK 427,9M | -3% |
| EBITDA | NOK 50M | +260% |
| Net profit | NOK -41,9M | -28% |
| Total assets | NOK 176,2M | -19% |
| Equity | NOK 79,4M | -35% |
| Employees | 48 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 585 835 | 434 000 | 453 836 | 440 978 | 427 902 |
| Staff expenses | −60 767 | −54 248 | −87 653 | −82 948 | −82 379 |
| EBITDA | 18 580 | 16 963 | −15 006 | −31 160 | 49 952 |
| Depreciation & amort. | −6 113 | −10 107 | −9 063 | −15 532 | −92 829 |
| EBIT | 12 467 | 6 857 | −24 069 | −46 692 | −42 877 |
| Net financials | 4 498 | 1 033 | 4 703 | 14 102 | 834 |
| Profit before tax | 16 966 | 7 890 | −19 366 | −32 590 | −42 043 |
| Tax | −0 | −0 | −0 | −0 | −190 |
| Net profit | 16 966 | 7 890 | −19 366 | −32 590 | −41 853 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 169 173 | 158 682 | 168 816 | 216 834 | 176 228 |
| Equity | 55 058 | 62 948 | 63 876 | 121 287 | 79 435 |
| Long-term debt | 0 | 23 000 | 23 000 | 23 000 | 23 000 |
| Short-term debt | 113 196 | 72 734 | 81 939 | 72 547 | 73 793 |
| Total debt | 113 196 | 95 734 | 104 939 | 95 547 | 96 793 |
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2020 – 2023 | |
| Chairman | 2020 – 2023 | |
| Chairman | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Mediq International B.V. | Company | 100% | 100% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Joachim Warnberg | Chairman | 0 companies |
| Rogier Stap | Board of Directors | 0 companies |
| Jan Henning Albrechtsen | Board of Directors | 0 companies |
| Philip Mørch Nadelmann | Chairman | 0 companies |
| Christian Kanstrup | Chairman | 0 companies |
| Trond Dahl Hansen | Chairman | 0 companies |
| Janke Berntsen Eriksen | Board of Directors | 0 companies |